Integrating Genomics and Proteomics to Identify Causal Proteins and Biologic Pathways for Incident Atrial Fibrillation in CKD
BACKGROUND: Chronic kidney disease (CKD) is strongly associated with atrial fibrillation. Understanding the biological pathways for this association and creating predictive models has been challenging. Left atrial enlargement is a substrate for atrial fibrillation but any overlap between biomarkers of atrial fibrillation and left atrial enlargement in individuals with CKD is unknown. METHODS: We evaluated 4,590 plasma proteins with SomaScan in two cohorts of adults with CKD: the Chronic Renal Insufficiency Cohort (CRIC, n=2,654) and the Atherosclerosis Risk in Communities Cohort (ARIC, n=1,326). Using Mendelian randomization, we identified proteins along the causal pathway to atrial fibrillation. We also identified proteins and corresponding pathways associated with larger echocardiographic left atrial size, a recognized substrate for atrial fibrillation. Lastly, we developed and validated a multi-protein risk score for incident atrial fibrillation in the CKD population. RESULTS: Over five years, incident atrial fibrillation occurred among 150 individuals in CRIC and 140 in ARIC. We identified three proteins causally linked to incident atrial fibrillation: neural epidermal growth factor like (NEL)-like protein 1 (NELL1), cartilage intermediate layer protein 2 (CILP2), and matrix metallopeptidase 12 (MMP12). Pathway analysis revealed an overlap in 8 of the top 10 canonical pathways for incident atrial fibrillation and left atrial enlargement. A risk model for incident atrial fibrillation comprised of proteins had annualized AUCs over 5 years ranging from 0.65 to 0.76, a performance similar to the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE AF) clinical risk score. CONCLUSIONS: This study identified causal proteins and biological mechanisms underlying incident atrial fibrillation in CKD. A proteomic risk score for incident atrial fibrillation in CKD performed similarly to CHARGE-AF.
Authors
- Ruth F. Dubin (ORCID: https://orcid.org/0000-0002-0498-1980)
- Mark R. Segal (ORCID: https://orcid.org/0000-0003-4213-3138)
- L Y Chen
- Hongzhe Lee
- Faye L. Norby (ORCID: https://orcid.org/0000-0002-1975-0405)
- Adrian Petzl (ORCID: https://orcid.org/0000-0002-8935-3560)
- Nisha Bansal (ORCID: https://orcid.org/0000-0002-9583-8628)
- J. Wang (ORCID: https://orcid.org/0000-0002-3281-8136)
- F M Francis E Marchlinski
- Paul L. Kimmel
- Yue Ren
- Morgan E Grams
- Alan S Go
- Aditya Surapaneni
- Ramachandran S Vasan
- Peter Ganz
- Rajat Deo
- Harold Feldman
- Alvaro Alonso
- Izabele Antanavicius
- Eugene P Rhee
Institutions
- San Francisco General Hospital (US)
- University of Minnesota (US)
- Kaiser Permanente (US)
- Harvard University (US)
- Emory University (US)
- The University of Texas at San Antonio Health Science Center (US)
- University of California, San Francisco (US)
- George Washington University (US)
- University of Washington Medical Center (US)
- Patient-Centered Outcomes Research Institute (US)
- Massachusetts General Hospital (US)
- The University of Texas at San Antonio (US)
- New York University (US)
- University of Pennsylvania (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Journal of the American Society of Nephrology
- Published
- 2026-05-01
- DOI
- https://doi.org/10.1681/asn.0000001117
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00